Figure 3.

The ELOVL2 Risk Score Model Predicts Overall Survival of Papillary Thyroid Carcinoma Patients in the Training Dataset

(A) Kaplan-Meier analyses for overall survival of patients with high-risk or low-risk scores. The p value was calculated using the two-sided log-rank test. (B) DNA methylation pattern, expression levels, and average methylation levels of the prognostic ELOVL2 that correlated with patients’ survival status and increased risk scores. (C) Box plot of the ELOVL2 risk scores in the four stages of papillary thyroid carcinoma.